Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
about
Differential expression and clinical significance of glioblastoma mRNA expression profiles in Uyghur and Han patients in Xinjiang provinceBone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.WNT signaling - lung cancer is no exception.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.
P2860
Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
@en
type
label
Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
@en
prefLabel
Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
@en
P2860
P1433
P1476
Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.
@en
P2093
Ali S Arbab
Sanath Kumar
P2860
P577
2013-08-01T00:00:00Z